- List
- By Topic
- On Map
- Search Details

"Guillain-Barre syndrome"
Need help? See RSS Feeds
Choose a feed type:

"Guillain-Barre syndrome" (26 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02582853 | Unknown † | sCD163 as a Potential Biomarker in Guillain- Barré Syndrome |
|
|
Observational |
|
Other |
|
60 | All | 18 Years to 100 Years (Adult, Senior) | NCT02582853 | GBS CD163 1-10-72-256-15 1-16-02-522-15 |
GBS | September 2015 | November 2016 | January 2018 | October 21, 2015 | October 22, 2015 |
|
|||
2 | NCT02780570 | Completed | Small Volume Plasma Exchange (SVPE) for Guillain-Barré Syndrome (GBS) Patients |
|
|
Interventional | Phase 2 |
|
Other |
|
|
20 | All | 18 Years to 65 Years (Adult) | NCT02780570 | PR-15086 | January 1, 2016 | December 31, 2016 | December 31, 2016 | May 23, 2016 | July 27, 2017 |
|
||
3 | NCT01306578 | Completed | Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS) |
|
|
Interventional | Not Applicable |
|
Other |
|
|
41 | All | 1 Month to 18 Months (Child) | NCT01306578 | MUCH-GBS | January 2007 | December 2009 | February 2010 | March 2, 2011 | March 2, 2011 |
|
||
4 | NCT02342184 | Completed | Efficacy and Safety Study of GB-0998 for Guillain-Barré Syndrome |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
21 | All | 16 Years and older (Child, Adult, Senior) | NCT02342184 | B211-13 | August 2014 | September 2015 | September 2015 | January 19, 2015 | February 4, 2016 |
|
||
5 | NCT00173199 | Unknown † | The Changes of Cytokines in Guillain Barré Syndrome: the Correlation With Clinical Manifestations and Skin Innervation |
|
Observational |
|
Other |
|
150 | All | Child, Adult, Senior | NCT00173199 | 9461700526 | June 2005 | September 15, 2005 | December 1, 2005 |
|
|||||||
6 | NCT01582763 | Recruiting | International Guillain-Barré Syndrome Outcome Study |
|
Observational |
|
Other |
|
|
4000 | All | Child, Adult, Senior | NCT01582763 | MEC-2011-477 3290 |
IGOS | May 2012 | June 2017 | January 2019 | April 23, 2012 | January 5, 2017 |
|
|||
7 | NCT00056810 | Completed | Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine |
|
|
Interventional | Phase 2 |
|
U.S. Fed |
|
|
30 | All | 19 Years to 75 Years (Adult, Senior) | NCT00056810 | 2129 | September 2002 | May 2005 | March 25, 2003 | March 25, 2015 |
|
|||
8 | NCT02459808 | Withdrawn | Gastrointestinal Transit Time in Patients With Guillain-Barré Syndrome |
|
Observational |
|
Other |
|
|
0 | All | 18 Years to 79 Years (Adult, Senior) | NCT02459808 | GBSTransitTimeAarhus | May 2015 | May 2018 | June 2, 2015 | January 23, 2018 |
|
|||||
9 | NCT02221271 | Completed | Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
22 | All | 18 Years and older (Adult, Senior) | NCT02221271 | NPB-01-13/C-01 | October 2014 | August 2015 | August 2015 | August 20, 2014 | April 12, 2017 |
|
||
10 | NCT00575653 | Completed | Safety Study of GBS Following Menactra Meningococcal Vaccination |
|
Observational |
|
Other / Industry |
|
|
6000000 | All | 11 Years to 21 Years (Child, Adult) | NCT00575653 | PH000274A | March 2005 | December 31, 2009 | December 31, 2010 | December 18, 2007 | March 16, 2017 |
|
||||
11 | NCT00004833 | Terminated | Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
170 | All | up to 17 Years (Child) | NCT00004833 | 199/13444 EUSM-076-97 EUSM-FDR001265 |
July 1995 | November 2002 | February 25, 2000 | April 7, 2015 | |||||
12 | NCT00167622 | Completed | Early Mechanical Ventilation for Guillain Barré Syndrome |
|
|
Interventional | Phase 2 |
|
Other |
|
|
50 | All | 18 Years and older (Adult, Senior) | NCT00167622 | P050103 PS050103 |
April 2005 | January 2009 | February 2009 | September 14, 2005 | July 20, 2016 |
|
||
13 | NCT02883270 | Completed | Effects of Robotic-assisted Gait Training In Non-Ambulatory Patients After Guillain-Barré Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
|
24 | All | 18 Years to 65 Years (Adult) | NCT02883270 | IRB2016-039-01 | August 2014 | August 2016 | August 2016 | August 30, 2016 | September 2, 2016 |
|
||
14 | NCT01024088 | Completed | Prospective Study on Swallowing/Breathing Interactions in Severe Guillain Barre Syndrome. |
|
Observational |
|
Other |
|
|
60 | All | 18 Years and older (Adult, Senior) | NCT01024088 | P061016 -CRC 06040 | DGVSB | March 2008 | July 2012 | July 2012 | December 2, 2009 | September 16, 2014 |
|
|||
15 | NCT02029378 | Unknown † | Inhibition of Complement Activation (Eculizumab) in Guillain-Barre Syndrome Study |
|
|
Interventional | Phase 2 |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT02029378 | GN12NE462 | ICA-GBS | September 2014 | October 2015 | March 2016 | January 7, 2014 | September 23, 2014 |
|
|
16 | NCT01005524 | Completed | Brain Computer Interface for Communication in ICU: a Feasibility Study |
|
Observational |
|
Other |
|
12 | All | 18 Years to 70 Years (Adult, Senior) | NCT01005524 | ANR-TecSan-2009 AFM2009 |
RoBIK-1 | January 2010 | March 2012 | May 2012 | November 2, 2009 | May 23, 2012 |
|
||||
17 | NCT01370200 | Completed | Regional Citrate Anticoagulation in Plasma Exchange Treatment |
|
|
Interventional | Not Applicable |
|
Other |
|
|
140 | All | 18 Years and older (Adult, Senior) | NCT01370200 | 111/09/09 | April 2011 | December 2014 | December 2014 | June 9, 2011 | May 27, 2015 |
|
||
18 | NCT01655394 | Unknown † | Change of Nerve Conduction Properties in IVIg Dependent Neuropathies |
|
Observational |
|
Other |
|
|
50 | All | 18 Years and older (Adult, Senior) | NCT01655394 | 01607831337 | October 2012 | December 2014 | June 2016 | August 1, 2012 | December 12, 2014 |
|
||||
19 | NCT03268304 | Not yet recruiting | Feasibility of Two New Software Modules for the Rehabilitation of Patients With Neuromuscular Upper Limb Impairments |
|
|
Observational |
|
Other |
|
|
75 | All | 18 Years and older (Adult, Senior) | NCT03268304 | KAYO | November 2017 | June 2018 | August 2018 | August 31, 2017 | September 26, 2017 | ||||
20 | NCT02722070 | Not yet recruiting | Processing Integration in Neurological Patients Using fMRI |
|
|
Observational |
|
Other |
|
|
150 | All | 18 Years to 85 Years (Adult, Senior) | NCT02722070 | 0657-15-HMO-CTIL | March 2016 | March 2020 | March 2025 | March 29, 2016 | March 29, 2016 | ||||
21 | NCT02493725 | Completed | JET-GBS - Japanese Eculizumab Trial for GBS |
|
|
Interventional | Phase 2 |
|
Other |
|
|
34 | All | 18 Years to 99 Years (Adult, Senior) | NCT02493725 | 100069 | July 2015 | May 2016 | October 2016 | July 9, 2015 | October 11, 2017 |
|
||
22 | NCT01469858 | Unknown † | Perception and Multisensory Integration in Neurological Patients Using fMRI |
|
|
Interventional | Not Applicable |
|
Other |
|
|
30 | All | 18 Years to 80 Years (Adult, Senior) | NCT01469858 | 044811HMO | November 2011 | November 2013 | November 2015 | November 10, 2011 | November 10, 2011 |
|
||
23 | NCT03206541 | Recruiting | Neurologic Manifestations of the Arbovirus Infection in Colombia |
|
Observational |
|
Other |
|
|
150 | All | 8 Years and older (Child, Adult, Senior) | NCT03206541 | IRB00093149 | January 1, 2016 | December 2018 | December 2018 | July 2, 2017 | July 2, 2017 |
|
||||
24 | NCT00271791 | Completed | Prednisone Treatment for Vestibular Neuronitis |
|
|
Interventional | Phase 2 |
|
Other |
|
|
17 | All | 18 Years and older (Adult, Senior) | NCT00271791 | 42352 20050277 |
September 2005 | May 2007 | January 4, 2006 | November 6, 2007 |
|
|||
25 | NCT00411216 | Completed Has Results |
Recovery of Visual Acuity in People With Vestibular Deficits |
|
|
Interventional | Not Applicable |
|
Other / NIH |
|
|
23 | All | 18 Years to 80 Years (Adult, Senior) | NCT00411216 | IRB00000336 R01DC003196 |
August 2000 | December 2004 | December 2004 | December 13, 2006 | August 7, 2015 | July 21, 2014 |
|
|
26 | NCT02422875 | Enrolling by invitation | Comparative Autoantibody and Immunologic Cell Marker Study |
|
Observational |
|
Other |
|
|
100 | All | 18 Years and older (Adult, Senior) | NCT02422875 | IRB00058515 | August 2012 | June 2020 | June 2020 | April 21, 2015 | August 2, 2017 |
|
† Study has passed its completion date and status has not been verified in more than two years.